A risk score based on baseline risk factors for predicting mortality in COVID-19 patients

References

• Zhang P, Zhu L, Cai J, et al. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020;126(12):1671–1681.
   PubMed Web of Science ®Google Scholar
• Emanuel EJ, Persad G, Upshur R, et al. Fair allocation of scarce medical resources in the time of COVID-19. N Engl J Med. 2020;382(21):2049–2055.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus disease (COVID-19) pandemic. Geneva: WHO; 2020.
   Google Scholar
• Liu H, Chen J, Yang Q, et al. Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients. Med. 2021. DOI:10.1016/j.medj.2020.12.013
   PubMed Web of Science ®Google Scholar
• Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5(1):33.
   PubMed Web of Science ®Google Scholar
• Bajwah S, Wilcock A, Towers R, et al. Managing the supportive care needs of those affected by COVID-19. Eur Respir J. 2020;55(4):2000815.
   PubMed Web of Science ®Google Scholar
• Cai J, Li H, Zhang C, et al. The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients with COVID-19. Cell Metab. 2021;33(2):258–269.e3.
   PubMed Web of Science ®Google Scholar
• Wynants L, Van Calster B, Bonten MMJ, et al. Prediction models for diagnosis and prognosis of COVID-19 infection: systematic review and critical appraisal. BMJ. 2020;369:m1328.
   PubMed Web of Science ®Google Scholar
• Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339.
   PubMed Web of Science ®Google Scholar
• National Health Commission of China. New Coronavirus Pneumonia Prevention and Control Program. National Health Commission of China. 2020. http://www.nhc.gov.cn.
   Google Scholar
• World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases Interim guidance. Geneva: World Health Organization; 2020.
   Google Scholar
• Stekhoven DJ, Buhlmann P. MissForest-non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28(1):112–118.
   PubMed Web of Science ®Google Scholar
• Bagherzadeh-Khiabani F, Ramezankhani A, Azizi F, et al. A tutorial on variable selection for clinical prediction models: feature selection methods in data mining could improve the results. J Clin Epidemiol. 2016;71:76–85.
   PubMed Web of Science ®Google Scholar
• Hastie T, Tibshirani R, Friedman J. Data mining, inference, and prediction. 2nd ed. Springer Series in Statistics. New York: Springer-Verlag; 2009.
   Google Scholar
• Liu X, Song M, Tao D, et al. Random forest construction with robust semisupervised node splitting. IEEE Trans Image Process. 2015;24(1):471–483.
   PubMed Web of Science ®Google Scholar
• Fox EW, Hill RA, Leibowitz SG, et al. Assessing the accuracy and stability of variable selection methods for random forest modeling in ecology. Environ Monit Assess. 2017;189(7):316.
   PubMed Web of Science ®Google Scholar
• Lin H, Long E, Ding X, et al. Prediction of myopia development among Chinese school-aged children using refraction data from electronic medical records: a retrospective, multicentre machine learning study. PLoS Med. 2018;15(11):e1002674.
   PubMed Web of Science ®Google Scholar
• Bramer M. Pre-pruning classification trees to reduce overfitting in noisy domains. Berlin, Heidelberg: Springer; 2002.
   Google Scholar
• Fürnkranz J. Pruning algorithms for rule learning. Machine Learning. 1997;27(2):139–172.
   Web of Science ®Google Scholar
• Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–227.
   PubMed Web of Science ®Google Scholar
• Mogensen UB, Ishwaran H, Gerds TA. Evaluating random forests for survival analysis using prediction error curves. J Stat Softw. 2012;50(11):1–23.
   PubMed Web of Science ®Google Scholar
• Epifanio I. Intervention in prediction measure: a new approach to assessing variable importance for random forests. BMC Bioinformatics. 2017;18(1):230.
   PubMed Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.
   PubMed Web of Science ®Google Scholar
• Stekhoven DJ. missForest: nonparametric missing value imputation using random forest [Internet]. 2013 [cited 2020 Nov 24]. Available from: https://cran.r-project.org/web/packages/missForest/index.html
   Google Scholar
• Waljee AK, Mukherjee A, Singal AG, et al. Comparison of imputation methods for missing laboratory data in medicine. BMJ Open. 2013;3(8):e002847.
   PubMed Web of Science ®Google Scholar
• Cozzi L, Dinapoli N, Fogliata A, et al. Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy. BMC Cancer. 2017;17(1):829.
   PubMed Web of Science ®Google Scholar
• Liang W, Liang H, Ou L, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081.
   PubMed Web of Science ®Google Scholar
• COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health [Internet]. 2020 [cited 2020 Nov 24]. Available from: https://www.covid19treatmentguidelines.nih.gov/
   Google Scholar
• Al-Gwaiz LA, Babay HH. The diagnostic value of absolute neutrophil count, band count and morphologic changes of neutrophils in predicting bacterial infections. Med Princ Pract. 2007;16(5):344–347.
   PubMed Web of Science ®Google Scholar
• Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–1812.
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363(9409):600–607.
   PubMed Web of Science ®Google Scholar
• Yang X, Jin Y, Li R, et al. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis. Crit Care. 2020;24(1):356.
   Google Scholar
• Liu YM, Xie J, Chen MM, et al. Kidney function indicators predict adverse outcomes of COVID-19. Med. 2021;2(1):38–48.e2.
   Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Qin JJ, Cheng X, Zhou F, et al. Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19. Hypertension. 2020;76(4):1104–1112.
   PubMed Web of Science ®Google Scholar
• Pranata R, Lim MA, Yonas E, et al. Body mass index and outcome in patients with COVID-19: a dose-response meta-analysis. Diab Metab. 2021;47(2):101178.
   PubMed Web of Science ®Google Scholar
• Gao YD, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76(2):428–455.
   PubMed Web of Science ®Google Scholar
• Guo L, Wei D, Zhang X, et al. Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score. Front Microbiol. 2019;10:2752.
   PubMed Web of Science ®Google Scholar
• Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382.
   PubMed Web of Science ®Google Scholar
• Zhu L, She ZG, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068–1077 e3.
   PubMed Web of Science ®Google Scholar
• Zhang XJ, Qin JJ, Cheng X, et al. In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell Metab. 2020;32(2):176–187 e4.
   PubMed Web of Science ®Google Scholar
• Cheng X, Liu YM, Li H, et al. Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;32(4):537–547 e3.
   PubMed Web of Science ®Google Scholar
• Liu PP, Blet A, Smyth D, et al. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142(1):68–78.
   PubMed Web of Science ®Google Scholar
• Zhou F, Liu YM, Xie J, et al. Comparative impacts of ACE (angiotensin-converting enzyme) inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality. Hypertension. 2020;76(2):e15–e7.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–582.
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239.
   PubMed Web of Science ®Google Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574.
   PubMed Web of Science ®Google Scholar
• Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020;28(7):1195–1199.
   PubMed Web of Science ®Google Scholar
• Caly L, Druce J, Roberts J, et al. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med J Aust. 2020;212(10):459–462.
   PubMed Web of Science ®Google Scholar